The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
MeSH Review


Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Catatonia


Psychiatry related information on Catatonia


High impact information on Catatonia


Chemical compound and disease context of Catatonia


Biological context of Catatonia


Anatomical context of Catatonia


Gene context of Catatonia


Analytical, diagnostic and therapeutic context of Catatonia


  1. What catatonia can tell us about "top-down modulation": a neuropsychiatric hypothesis. Northoff, G. The Behavioral and brain sciences. (2002) [Pubmed]
  2. Fever, tachycardia, and hypertension with acute catatonic schizophrenia. McAllister, R.G. Arch. Intern. Med. (1978) [Pubmed]
  3. Influenza RNA not detected in archival brain tissues from acute encephalitis lethargica cases or in postencephalitic Parkinson cases. McCall, S., Henry, J.M., Reid, A.H., Taubenberger, J.K. J. Neuropathol. Exp. Neurol. (2001) [Pubmed]
  4. Catatonia and mania: patterns of cerebral dysfunction. Abrams, R., Taylor, M.A., Coleman Stolurow, K.A. Biol. Psychiatry (1979) [Pubmed]
  5. Case series: catatonic syndrome in young people. Cohen, D., Flament, M., Dubos, P.F., Basquin, M. Journal of the American Academy of Child and Adolescent Psychiatry. (1999) [Pubmed]
  6. Synergism of lorazepam and electroconvulsive therapy in the treatment of catatonia. Petrides, G., Divadeenam, K.M., Bush, G., Francis, A. Biol. Psychiatry (1997) [Pubmed]
  7. Clinical and pharmacologic risk factors for neuroleptic malignant syndrome: a case-control study. Berardi, D., Amore, M., Keck, P.E., Troia, M., Dell'Atti, M. Biol. Psychiatry (1998) [Pubmed]
  8. The DST and its relationship to psychiatric diagnosis, symptoms and treatment outcome. Klein, H.E., Bender, W., Mayr, H., Niederschweiberer, A., Schmauss, M. The British journal of psychiatry : the journal of mental science. (1984) [Pubmed]
  9. PANDAS with catatonia: a case report. Therapeutic response to lorazepam and plasmapheresis. Elia, J., Dell, M.L., Friedman, D.F., Zimmerman, R.A., Balamuth, N., Ahmed, A.A., Pati, S. Journal of the American Academy of Child and Adolescent Psychiatry. (2005) [Pubmed]
  10. Acute exposure to maneb alters some behavioral functions in the mouse. Morato, G.S., Lemos, T., Takahashi, R.N. Neurotoxicology and teratology. (1989) [Pubmed]
  11. Test for catatonia with zolpidem. Thomas, P., Rascle, C., Mastain, B., Maron, M., Vaiva, G. Lancet (1997) [Pubmed]
  12. Response of organic catatonia to risperidone. Cook, E.H., Olson, K., Pliskin, N. Arch. Gen. Psychiatry (1996) [Pubmed]
  13. Exclusion of the neuronal nicotinic acetylcholine receptor alpha7 subunit gene as a candidate for catatonic schizophrenia in a large family supporting the chromosome 15q13-22 locus. Meyer, J., Ortega, G., Schraut, K., Nürnberg, G., Rüschendorf, F., Saar, K., Mössner, R., Wienker, T.F., Reis, A., Stöber, G., Lesch, K.P. Mol. Psychiatry (2002) [Pubmed]
  14. Efavirenz-induced catatonia. Sabato, S., Wesselingh, S., Fuller, A., Ray, J., Mijch, A. AIDS (2002) [Pubmed]
  15. A missense mutation in a novel gene encoding a putative cation channel is associated with catatonic schizophrenia in a large pedigree. Meyer, J., Huberth, A., Ortega, G., Syagailo, Y.V., Jatzke, S., Mössner, R., Strom, T.M., Ulzheimer-Teuber, I., Stöber, G., Schmitt, A., Lesch, K.P. Mol. Psychiatry (2001) [Pubmed]
  16. Psychogenic catatonia treated with lorazepam. Ripley, T.L., Millson, R.C. The American journal of psychiatry. (1988) [Pubmed]
  17. Disulfiram encephalopathy as a cause of the catatonia syndrome. Weddington, W.W., Marks, R.C., Verghese, J.P. The American journal of psychiatry. (1980) [Pubmed]
  18. Dantrolene in lethal catatonia. Pennati, A., Sacchetti, E., Calzeroni, A. The American journal of psychiatry. (1991) [Pubmed]
  19. Treatment-refractory catatonia, ECT, and parenteral lorazepam. Koek, R.J., Mervis, J.R. The American journal of psychiatry. (1999) [Pubmed]
  20. Lithium in the treatment of periodic catatonia: a case report. Wald, D., Lerner, J. The American journal of psychiatry. (1978) [Pubmed]
  21. Preclinical and clinical studies with somatostatin related to the central nervous system. Vécsei, L., Widerlöv, E. Prog. Neuropsychopharmacol. Biol. Psychiatry (1990) [Pubmed]
  22. Triplet repeats in clinical subtypes of schizophrenia: variation at the DRPLA (B 37 CAG repeat) locus is not associated with periodic catatonia. Lesch, K.P., Stöber, G., Balling, U., Franzek, E., Li, S.H., Ross, C.A., Newman, M., Beckmann, H., Riederer, P. J. Neural Transm. Gen. Sect. (1994) [Pubmed]
  23. Systematic mutation analysis of KIAA0767 and KIAA1646 in chromosome 22q-linked periodic catatonia. Stöber, G., Kohlmann, B., Iekiera, M., Rubie, C., Gawlik, M., Möller-Ehrlich, K., Meitinger, T., Bettecken, T. BMC psychiatry [electronic resource]. (2005) [Pubmed]
  24. Myelin basic protein antibodies in catatonic schizophrenia. Rimón, R., Ahokas, A., Ruutiainen, J., Halonen, P. The Journal of clinical psychiatry. (1986) [Pubmed]
  25. Paradoxical opiate specific paralytic effects of high doses of intracerebroventricular etorphine and fentanyl in rats. Leshem, M., Frenk, H., Coghill, R.C., Mayer, D.J. Pharmacol. Biochem. Behav. (1991) [Pubmed]
  26. No causative DLL4 mutations in periodic catatonia patients from 15q15 linked families. McKeane, D.P., Meyer, J., Dobrin, S.E., Melmed, K.M., Ekawardhani, S., Tracy, N.A., Lesch, K.P., Stephan, D.A. Schizophr. Res. (2005) [Pubmed]
  27. Baclofen-induced catatonia: modification by serotonergic agents. Kasture, S.B., Mandhane, S.N., Chopde, C.T. Neuropharmacology (1996) [Pubmed]
  28. Neuroleptic malignant syndrome with prolonged catatonia in a dopa-responsive dystonia patient. Ihara, M., Kohara, N., Urano, F., Ichinose, H., Takao, S., Nishida, T., Saiki, H., Kawamoto, Y., Ikeda, A., Takagi, S., Shibasaki, H. Neurology (2002) [Pubmed]
  29. NMS and lethal catatonia. Weller, M. The Journal of clinical psychiatry. (1992) [Pubmed]
  30. MLC1 polymorphisms are specifically associated with periodic catatonia, a subgroup of chronic schizophrenia. Selch, S., Strobel, A., Haderlein, J., Meyer, J., Jacob, C.P., Schmitt, A., Lesch, K.P., Reif, A. Biol. Psychiatry (2007) [Pubmed]
  31. Plasma homovanillic acid concentrations in catatonia. Northoff, G., Demisch, L., Wenke, J., Pflug, B. Biol. Psychiatry (1996) [Pubmed]
  32. Neuroleptic-induced catatonia: case report. Johnson, G.C., Manning, D.E. The Journal of clinical psychiatry. (1983) [Pubmed]
  33. Case study: effectiveness of plasma exchange in an adolescent with systemic lupus erythematosus and catatonia. Perisse, D., Amoura, Z., Cohen, D., Saintigny, P., Mekhloufi, F., Mazet, P., Piette, J.C. Journal of the American Academy of Child and Adolescent Psychiatry. (2003) [Pubmed]
  34. 'Catatonia' produced by alfentanil is reversed by methylnaloxonium microinjections into the brain. Amalric, M., Blasco, T.A., Smith, N.T., Lee, D.E., Swerdlow, N.R., Koob, G.F. Brain Res. (1986) [Pubmed]
  35. Catatonia. II. Treatment with lorazepam and electroconvulsive therapy. Bush, G., Fink, M., Petrides, G., Dowling, F., Francis, A. Acta psychiatrica Scandinavica. (1996) [Pubmed]
WikiGenes - Universities